Hypertension High Cholesterol Type 2 Diabetes Obstructive Sleep Apnea Cardiovascular Disease It is not advisable for patients to take this medication if any of the following apply: Insulin users Type 1 Diabetes Mellitus (Insulin Dependent) diagnosis History of Diabetic Retinopathy Personal or family history of Medullary Thyroid Cancer or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2) Personal or family history of pancreatitis, or certain liver or kidney problems Allergy to medication being administered Pregnant or breastfeeding individuals Previous history of an eating disorder BMI less than 18.5 Under 18 years of age Nausea Diarrhea Vomiting Constipation Abdominal pain Increased heart rate Headache Congestion Fatigue Indigestion Dizziness From day one, we provide comprehensive, compassionate support to help you feel empowered
81,107,109 Tanzeum was discontinued by GlaxoSmithKline (GSK) in 2017, primarily due to economic factors
As research on GLP-1RAs expands in the cognitive and mental health area, we may be able to distinguish between direct effects on cognitive and mental health outcomes and effects that are mediated by GLP-1RAs actions on cardiovascular and metabolic outcomes
Factors for Employers to Consider in Coverage Decisions When assessing health plan coverage, employers must carefully weigh several factors to make informed decisions that benefit their employees while managing costs effectively
AOM trial: Patients with obesity but without T2D, comparing newer GLP-1 RAs to older GLP-1 RAs and other anti-obesity medications (AOMs)
